SEC Form 4 · accession 0001209191-16-089945
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Parini
Officer — EVP & CLO
Period of report
Jan 4, 2016
Accepted (ET)
Jan 6, 2016 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 4, 2016 | A | 13,800 | $0.01 | A | 13,800 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $122.45 | Jan 4, 2016 | A | 68,000 | A | — | Jan 3, 2026 | Common Stock | 68,000 | 68,000 | D |
Explanation of responses
- F1Stock grant under 2013 Stock and Option Plan, vesting in four annual installments from 01/04/2016.
- F2The option vests in 16 quarterly installments from 01/04/2016.